SCHEMBL1064124

SCHEMBL1064124

O=C1NC(=O)C(=Cc2ccc(-c3ccccc3)s2)S1

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.75
PRF1 P14222 1/20 0.61
PIM1 P11309 1/20 0.59
PIM3 Q86V86 1/20 0.59
PIM2 Q9P1W9 1/20 0.59
GSK3B P49841 2/20 0.55
PIK3CG P48736 2/20 0.54
PIK3CA P42336 1/20 0.54
AKR1B1 P15121 3/20 0.51
HPGD P15428 1/20 0.51
TTR P02766 2/20 0.50
NAT1 P18440 2/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
MAOA P21397 1/20 0.49
MAOB P27338 1/20 0.49
IGF1R P08069 1/20 0.49
PPARA Q07869 1/20 0.48
NR1H4 Q96RI1 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1064121 1.00 TDP1 (0.75) TDP1PRF1PIM1PIM3PIM2
SCHEMBL5142931 0.86 PIK3CG (0.61) TDP1PRF1PIM1PIM3PIM2
SCHEMBL5142934 0.86 PIK3CG (0.61) TDP1PRF1PIM1PIM3PIM2
SCHEMBL12931803 0.86 PIM1 (0.63) TDP1PRF1PIM1PIM3PIM2
SCHEMBL623594 0.86 TDP1 (0.60) TDP1PRF1PIM1PIM3PIM2
SCHEMBL14860890 0.86 TDP1 (1.00) TDP1PRF1MEN1KMT2A
SCHEMBL14860889 0.86 TDP1 (1.00) TDP1PRF1MEN1KMT2A
SCHEMBL14860888 0.86 TDP1 (1.00) TDP1PRF1MEN1KMT2A
SCHEMBL12961661 0.86 PRF1 (0.59) TDP1PRF1PIM1PIM3PIM2
SCHEMBL623593 0.86 TDP1 (0.60) TDP1PRF1PIM1PIM3PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735445-B2 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages L'OREAL (FR) 2014-05-27 US disclosed
EP-1594438-B1 Use of an inhibitor of 15-hydroxyprostaglandin dehydrogenase in order to stimulate pigmentation of the skin or hair OREAL (FR) 2013-07-17 EP disclosed
US-20110014250-A1 INHIBITORS OF 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE FOR STIMULATING PIGMENTATION OF THE SKIN OR SKIN APPENDAGES L'OREAL (FR) 2011-01-20 US disclosed
US-7705041-B2 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages L'OREAL (FR) 2010-04-27 US disclosed
US-7705041-B2 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages L'OREAL (FR) 2010-04-27 US disclosed
US-20080076809-A1 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss composition comprising it and its uses SOCIETE L'OREAL S.A. (FR) 2008-03-27 US disclosed
US-20080076809-A1 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss composition comprising it and its uses SOCIETE L'OREAL S.A. (FR) 2008-03-27 US disclosed
US-7294641-B2 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss, composition comprising it and its uses L'OREAL (FR) 2007-11-13 US disclosed
US-7294641-B2 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss, composition comprising it and its uses L'OREAL (FR) 2007-11-13 US disclosed
US-20060034786-A1 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages L'OREAL (FR) 2006-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076809-A1 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss composition comprising it and its uses KRT18, FGF1, SHH TDP1 4001/4885PRF1 2632/4885PIM1 4417/4885
US-20060034786-A1 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages COX15, HPGD, TYR TDP1 2202/4885PRF1 3750/4885PIM1 2801/4885
US-20110014250-A1 INHIBITORS OF 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE FOR STIMULATING PIGMENTATION OF THE SKIN OR SKIN APPENDAGES COX15, HPGD, TYR TDP1 2202/4885PRF1 3750/4885PIM1 2801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.